We further demonstrated that the endocytosis inhibitor PCZ effectively inhibited both EGFR and EGFR‐cetuximab complexes, dramatically increasing the tumor cell‐killing efficacy by enhancing the ADCC effect. Here, EGFR is linked to neoplasm.